What is the term for the constant urge to move (restlessness) experienced with antipsychotic medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Akathisia

The term for the constant urge to move and inner restlessness experienced with antipsychotic medications is akathisia.

Definition and Clinical Presentation

Akathisia is characterized by both subjective feelings of inner restlessness and an objective, compulsive urge to move 1, 2. This distressing extrapyramidal symptom manifests as an inability to sit still, with patients experiencing intense internal discomfort that drives them to constantly shift position, pace, or move their limbs.

Key Clinical Features

  • Subjective component: Inner sense of restlessness and agitation
  • Objective component: Observable motor restlessness (pacing, fidgeting, inability to remain seated)
  • Timing: Can occur even at low, introductory doses of antipsychotics 1
  • Severity: Ranges from mild discomfort to severe distress that significantly impacts quality of life

Antipsychotic Risk Profile

While traditionally associated with first-generation antipsychotics, akathisia occurs with second-generation agents as well. Aripiprazole and lurasidone are notable second-generation antipsychotics that can precipitate severe akathisia even at low doses 1. This underscores the need for vigilant monitoring regardless of which generation of antipsychotic is prescribed.

Management Approach

Per APA guidelines, when akathisia occurs with antipsychotic therapy, the following options should be considered (2C recommendation): 3

  1. Lower the dosage of the current antipsychotic medication
  2. Switch to another antipsychotic medication with lower akathisia risk
  3. Add a benzodiazepine medication
  4. Add a beta-adrenergic blocking agent

For treatment-resistant cases where standard interventions (benzodiazepines like clonazepam, anticholinergics like benztropine) fail, mirtazapine at low doses (15 mg) has demonstrated efficacy in resolving severe, persistent akathisia 2.

Critical Clinical Pitfall

Do not confuse akathisia with restless legs syndrome (RLS) 4. While both involve an urge to move, akathisia is a whole-body phenomenon with inner restlessness affecting the entire person, whereas RLS is typically localized to the legs and occurs primarily at rest or during sleep. Misdiagnosis can lead to inappropriate treatment escalation rather than addressing the underlying medication-induced cause.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.